文献速递重症综合管理与镇静镇痛儿科与产科急症

接受体外膜氧合儿童出血与血栓形成相关因素

Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01
一句话结论儿童ECMO期间出血发生率达70.2%、血栓12.8%,出血独立关联每日死亡风险升高,实验室采血是输血主因。

这项前瞻性观察性队列研究在8家医院儿科、心脏和新生儿重症监护病房开展,2012年12月至2014年9月连续纳入514例19岁以下接受ECMO的患者。结果示生存率54.9%,出血发生70.2%(颅内出血16%),出血独立关联更高的每日死亡风险;31.1%需更换管路组件,12.8%发生患者相关血栓。实验室采血导致56.6%患者需输血,且是42.2%患者至少一次输血的唯一原因。溶血可预测后续血栓事件,但溶血和血栓事件均未增加死亡风险。

要点

  • 514例19岁以下ECMO患儿中出血发生70.2%、颅内出血16%,出血独立关联更高的每日死亡风险。
  • 患者相关血栓发生12.8%,31.1%需更换管路组件;溶血可预测后续血栓事件,但溶血与血栓均未增加死亡风险。
  • 实验室采血导致56.6%患儿需输血,且是42.2%患儿至少一次输血的唯一原因。
  • 泵类型与出血、血栓、溶血或死亡均无关联。
  • 生存率54.9%;作者认为减少每日出血与血栓风险及不同输血阈值的策略可作为未来试验的合适主题。

适用人群与场景

  • 8家医院儿科、心脏和新生儿重症监护病房中连续纳入的19岁以下接受ECMO支持的患者,共514例。

红旗征与不能漏的情况

  • 出血(需输血的失血或颅内出血)发生70.2%,其中颅内出血16%,出血独立关联更高的每日死亡风险。
  • 溶血可预测后续血栓事件。

研究设计与关键结果

  • 前瞻性观察性队列研究,8家医院,2012年12月至2014年9月连续纳入514例19岁以下ECMO患者。
  • 生存率54.9%;出血发生70.2%(颅内出血16%),出血独立关联更高的每日死亡风险。
  • 31.1%需更换管路组件,患者相关血栓12.8%;溶血可预测后续血栓事件,溶血与血栓事件均未增加死亡风险。
  • 实验室采血导致56.6%患者需输血,且是42.2%患者至少一次输血的唯一原因。
  • 泵类型与出血、血栓、溶血或死亡均无关联。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,减少每日出血和血栓风险的策略以及不同的输血阈值可能是未来试验的合适主题,以改善需要该支持治疗儿童的结果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Extracorporeal membrane oxygenation (ECMO) is used for respiratory and cardiac failure in children but is complicated by bleeding and thrombosis.

OBJECTIVES: (1) To measure the incidence of bleeding (blood loss requiring transfusion or intracranial hemorrhage) and thrombosis during ECMO support; (2) to identify factors associated with these complications; and (3) to determine the impact of these complications on patient outcome.

METHODS: This was a prospective, observational cohort study in pediatric, cardiac, and neonatal intensive care units in eight hospitals, carried out from December 2012 to September 2014.

MEASUREMENTS AND MAIN RESULTS: ECMO was used on 514 consecutive patients under age 19 years. Demographics, anticoagulation practices, severity of illness, circuitry components, bleeding, thrombotic events, and outcome were recorded. Survival was 54.9%. Bleeding occurred in 70.2%, including intracranial hemorrhage in 16%, and was independently associated with higher daily risk of mortality. Circuit component changes were required in 31.1%, and patient-related clots occurred in 12.8%. Laboratory sampling contributed to transfusion requirement in 56.6%, and was the sole reason for at least one transfusion in 42.2% of patients. Pump type was not associated with bleeding, thrombosis, hemolysis, or mortality. Hemolysis was predictive of subsequent thrombotic events. Neither hemolysis nor thrombotic events increased the risk of mortality.

CONCLUSIONS: The incidences of bleeding and thrombosis are high during ECMO support. Laboratory sampling is a major contributor to transfusion during ECMO. Strategies to reduce the daily risk of bleeding and thrombosis, and different thresholds for transfusion, may be appropriate subjects of future trials to improve outcomes of children requiring this supportive therapy.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Dalton HJ, Reeder R, Garcia-Filion P, et al. Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation. Am J Respir Crit Care Med. 2017. PMID: 28328243. doi:10.1164/rccm.201609-1945OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。